| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2004 | CA2491011A1 Cationic linear peptides having antibacterial and/or antifungal properties |
| 01/15/2004 | CA2490983A1 Immunostimulation by chemically modified rna |
| 01/15/2004 | CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | CA2489919A1 Liposomal vaccine |
| 01/15/2004 | CA2489196A1 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 01/15/2004 | CA2488725A1 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/14/2004 | EP1380654A1 Multiplex PCR primer set for human glucokinase gene amplification |
| 01/14/2004 | EP1380651A2 Recombinant fowlpox virus with intact FPV-tk-gene |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380649A1 Transformant producing pf1022 substance derivatives, process for producing the same and novel biosynthesis gene |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380647A1 Deoxymugineic acid synthase and gene thereof |
| 01/14/2004 | EP1380646A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1380643A1 Process, construct and conjugate for producing multiple nucleic acid copies |
| 01/14/2004 | EP1380642A1 A method for the separation and purification of nucleic acid |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380592A1 Cell surface layer-binding protein and utilization thereof |
| 01/14/2004 | EP1380338A2 Method for producing a microarray |
| 01/14/2004 | EP1380289A1 Delivery system for pharmaceutical agents |
| 01/14/2004 | EP1380001A2 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 01/14/2004 | EP1379880A2 Screening for drugs against disorders associated with schizophrenia |
| 01/14/2004 | EP1379879A2 Diagnosis and treatment of alzheimer's disease |
| 01/14/2004 | EP1379878A2 Affinity selection-based screening of hydrophobic proteins |
| 01/14/2004 | EP1379876A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase |
| 01/14/2004 | EP1379873A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 01/14/2004 | EP1379868A2 Transgenic zebrafish models for neurodegenerative diseases |
| 01/14/2004 | EP1379852A1 Multi-format sample processing devices, methods and systems |
| 01/14/2004 | EP1379701A2 Elimination of endogenous porcine retrovirus |
| 01/14/2004 | EP1379699A2 Detection of fungal pathogens using the polymerase chain reaction |
| 01/14/2004 | EP1379698A1 Mobility-modified nucleobase polymers and methods of using same |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379694A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 01/14/2004 | EP1379692A1 Nucleic acid analysis using non-templated nucleotide addition |
| 01/14/2004 | EP1379691A1 Differentially methylated sequences in pancreatic cancer |
| 01/14/2004 | EP1379690A1 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof |
| 01/14/2004 | EP1379689A2 Oligonucleotide conjugates |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379686A2 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
| 01/14/2004 | EP1379685A2 Assay for the detection and quantitation of hemimethylation |
| 01/14/2004 | EP1379684A2 Method and system for detecting nucleic acids |
| 01/14/2004 | EP1379683A2 Methods of identification and isolation of polynucleotides containing nucleic acid differences |
| 01/14/2004 | EP1379677A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |
| 01/14/2004 | EP1379675A1 Method for the oxidation of aromatic compounds |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379671A2 Methods to culture circovirus |
| 01/14/2004 | EP1379669A2 Plant stress regulated genes |
| 01/14/2004 | EP1379668A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells |
| 01/14/2004 | EP1379667A2 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 01/14/2004 | EP1379666A2 Recombinant dimorphic fungal cell |
| 01/14/2004 | EP1379665A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 01/14/2004 | EP1379664A1 Mhc tetramers |
| 01/14/2004 | EP1379663A2 Terpene synthase/cyclase and olefin synthase and uses thereof |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379661A2 Regulation of human gnat acetyltransferase-like protein |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |
| 01/14/2004 | EP1379659A2 Oryza sativa nuclear cap binding protein 80 |
| 01/14/2004 | EP1379658A2 Antimicrobial peptides and methods of use |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379655A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379653A2 Testis protein, zsig86 |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379647A2 Mammalian cytokines; receptors; related reagents and methods |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379645A2 Isolation of dna molecules using mercapto-aryl ligands |
| 01/14/2004 | EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies |
| 01/14/2004 | EP1379642A2 Arrayed transfection method and uses related thereto |
| 01/14/2004 | EP1379641A2 Process for the production and purification of secreted proteins and the production of arrays of proteins |
| 01/14/2004 | EP1379639A2 Glucuronyl c5-epimerase, dna encoding the same and uses thereof |
| 01/14/2004 | EP1379638A2 Implantation serine proteinases |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379626A2 A method for differentiating stem cells into insulin-producing cells |
| 01/14/2004 | EP1379624A2 Transfection of human embryonic stem cells |
| 01/14/2004 | EP1379555A2 Modified interferon alpha with reduced immunogenicity |
| 01/14/2004 | EP1379554A2 Proteins, polynucleotides encoding them and methods of using the same |
| 01/14/2004 | EP1379552A1 Toll-like receptor 5 ligands and methods of use |
| 01/14/2004 | EP1379551A2 Adp-ribosylating bacterial toxins |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379549A2 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/14/2004 | EP1379539A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 01/14/2004 | EP1379538A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 01/14/2004 | EP1379537A2 Pcr-hybridization assays specific for integrated retroviruses |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379281A2 A helper dependent adenoviral vector system and methods for using the same |
| 01/14/2004 | EP1379277A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379273A2 Nucleic acid adjuvants |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379268A1 Chondrogenic potential of human bone marrow-derived cd105?+ cells by bmp |